These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9789824)

  • 1. Cholinergic foundations of Alzheimer's disease therapy.
    Giacobini E
    J Physiol Paris; 1998; 92(3-4):283-7. PubMed ID: 9789824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Alzheimer's disease. New developments.
    Giacobini E; Michel JP
    Ann Med Interne (Paris); 1998 Jun; 149(4):231-7. PubMed ID: 11490551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
    Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
    Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors stabilize Alzheimer's disease.
    Giacobini E
    Ann N Y Acad Sci; 2000; 920():321-7. PubMed ID: 11193171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
    Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of donepezil in the treatment of Alzheimer's disease.
    Doody RS
    Gerontology; 1999; 45 Suppl 1():23-32. PubMed ID: 9876215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP
    CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is anti-cholinesterase therapy of Alzheimer's disease delaying progression?
    Giacobini E
    Aging (Milano); 2001 Jun; 13(3):247-54. PubMed ID: 11442306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.
    Rockwood K
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):677-85. PubMed ID: 15090558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
    Standridge JB
    Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with cholinesterase inhibitors.
    Defilippi JL; Crismon ML
    Drugs Aging; 2003; 20(6):437-44. PubMed ID: 12710863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cholinesterase inhibitors in Alzheimer disease].
    Sampalmieri M; Troiani MP; Servi M
    Clin Ter; 1993 Dec; 143(6):549-52. PubMed ID: 8306579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.
    Paterson RW; Abdi Z; Haines A; Schott JM
    Clin Neurol Neurosurg; 2016 May; 144():64-6. PubMed ID: 26989943
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinesterase inhibitors stabilize Alzheimer disease.
    Giacobini E
    Neurochem Res; 2000 Oct; 25(9-10):1185-90. PubMed ID: 11059792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.